Feline osteoarthritis is extremely common but dramatically underdiagnosed. Effective treatments exist that can transform quality of life for affected cats.
Feline OA represents a massive, largely invisible welfare burden in the companion cat population. The combination of high prevalence, subtle presentation, and owner attribution to normal ageing means that the majority of arthritic cats never receive appropriate diagnosis or treatment. In reality, feline OA is a painful condition causing chronic welfare compromise, and effective treatments including anti-NGF therapy now exist that provide meaningful pain relief. The introduction of Solensia has been a watershed moment for feline pain management: a monthly injection that owners appreciate because it avoids the stress of daily pilling, and that cats appreciate because it provides sustained pain control. Screening older cats routinely for OA signs is one of the highest-welfare interventions available to companion cat medicine.